Human Cell-Based Assays

Fast.

Predictive.

Competitive.

Who We Are

At innoVitro, our team of scientists and engineers leads the industry in human-based cell analytics.

Our cutting-edge technologies focus on speed, label-free operations, and real-time analysis. We excel in assessing functional and structural cellular readouts – including cell contractility, viability, and connectivity – with unmatched precision and throughput.

Get in touch

Cell-Based Assay Services

Explore our cell-based assay services, designed to monitor dynamic functional and cellular changes over time to gain valuable insights into contractile, morphological or general cellular responses.

Technologies

Discover our state-of-the-art cell-based assay technologies, the cornerstone of our services designed to elevate your cellular research fast and effectively!

Latest News

Meet us at the 3rd Microphysiological Systems World Summit (MPS) in Seattle, USA

Visit our booth at the 3rd MPS World Summit taking place in the Seattle Convention Center, from June 10th to 14th, 2024. Stay tuned for more information regarding posters and presentations.

Meet us at the Society of Toxicology in Salt Lake City, USA

Get ready to meet us at the 63rd SOT Annual Meeting & ToxExpo in Salt Lake City, March 10-14th, 2024. Stop by our booth 1832 to learn about our cell-based assay services!

Our Trusted Partners & Clients

innoVitro exemplifies outstanding customer service with a readily available and fantastic team. As members of the HESI Cardiac Safety Technical Committee, they are dedicated to improving public health by reducing unexpected cardiovascular side effects. Their up-to-date insights and expertise in diverse assays make them an exceptional collaborative partner.
Sonja Stölzle-Feix
Director Scientific Affairs
As long as we do not allow cells in culture to behave like mature cells, we should not expect them to do so!
Peter Linder MSc
CTO, Founder
We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly.
Nina Glaser
Head of Early Safety Electrophysiology
The FLEXcyte brings another dimension to iPS-derived cardiomyocyte based assays. Measuring contractility in such a direct and easy way allows us to understand the cell functionality better and will help us in both our product development and safety pharmacology research.
Choong-seong (Henry) Han DDS PhD
CEO, Founder
  • O
  • O
  • O
  • O